Anti-Human CD248 Recombinant Antibody
-
产品编号
YR1332
-
别名
科研级 Ontuxizumab ( 昂妥昔珠单抗 ), Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab
-
规格
- 1mg
- 5mg
Catalog Number | YR1332 |
Alias | 科研级 Ontuxizumab ( 昂妥昔珠单抗 ), Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab |
Size | 1mg, 5mg |
Molecular Name | Ontuxizumab |
CAS Number | 946415-62-9 |
Target | CD248[Homo sapiens] |
Host | Mouse |
Antibody Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Formulation | PBS, pH7.5 |
Shipping Condition | Shipped on ice packs. |
Background | Ontuxizumab is a humanized rabbit monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1 or CD248). Phase I trials are complete and the drug was granted orphan drug status by the FDA for sarcoma. It is currently in phase II trials for melanoma, colorectal cancer, sarcoma, and lymphoma. This drug was developed by Morphotek and Ludwig Institute for Cancer Research. |
Application | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Remarks | This product is for research use only. |